Colfax Corporation CFX
Day range unavailable
52-week range unavailable
- Market cap
- 2.10B
- Revenue (ttm)
- 3.85B
- Profit margin
- 1.86%
- Shares out
- 53.78M
- Forward P/E
- 14.52
- Beta
- 2.12
- Analysts
- Buy
- Price target
- 50.42 (+29.1%)
- Earnings date
- May 5, 2022
2Y -13.79 (-26.09%)
Key statistics
- Enterprise value
- 5.39B
- PEG ratio
- 1.13
- Price / sales
- 0.54
- Price / book
- 0.44
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 23.60%
- Free cash flow
- 264.89M
- Total cash
- 719.37M
- Total debt
- 2.27B
- Return on equity
- 2.39%
- Short % of float
- 5.57%
- 50-day average
- 69.21
- 200-day average
- 78.15
Analyst view
Consensus: buy
- Target (low)
- 37.00
- Target (mean)
- 50.42
- Target (high)
- 65.00
- Strong buy4
- Buy4
- Hold8
- Sell0
- Strong sell1
Next earnings
May 5, 2022
Expected May 5, 2022. Consensus EPS estimate 0.52.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 5, 2022 | Mar 1, 2022 | 0.49 | — | — | — |
| Feb 22, 2022 | Dec 1, 2021 | 0.57 | — | — | — |
| Nov 4, 2021 | Sep 1, 2021 | 0.54 | — | — | — |
| Jul 28, 2021 | Jun 1, 2021 | 0.53 | — | — | — |
| Apr 29, 2021 | Mar 1, 2021 | 0.39 | — | — | — |
| Feb 18, 2021 | Dec 1, 2020 | 0.49 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 15, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Mar 15, 2022 | Keybanc | main | — | Overweight |
| Feb 23, 2022 | Stifel | main | — | Buy |
| Feb 8, 2022 | Seaport Global | down | Buy | Neutral |
| Jan 28, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Jan 14, 2022 | Morgan Stanley | main | — | Equal-Weight |
About Colfax Corporation
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.
- Sector
- Industrials
- Industry
- Specialty Industrial Machinery
- Country
- United States
- Website
- colfaxcorp.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on CFX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALLENDER PATRICK W | Director | Stock Award(Grant) | Dec 30, 2021 | 291,055 |
| HIX CHRISTOPHER M | Chief Financial Officer | Sale | Feb 28, 2022 | 143,417 |
| KAMBEYANDA SHYAM | Officer | Sale | Mar 6, 2022 | 100,985 |
| LANG PATRICIA A | Officer | Sale | Mar 6, 2022 | 33,105 |
| PITTS DOUGLAS J | Officer | Sale | Feb 27, 2022 | 9,032 |
| PRYOR DANIEL A | Officer | Sale | Mar 6, 2022 | 205,487 |
